Mads Krogsgaard Thomsen (Novo Nordisk Foundation)
February 3, 2021 10:36 AM EST
People

Mads Krogs­gaard Thom­sen hands off CSO job at No­vo Nordisk af­ter a 30-year run, then piv­ots to CEO post at huge No­vo Foun­da­tion

John Carroll

Editor & Founder

An­oth­er long­time Big Phar­ma R&D chief is hit­ting the ex­it.

No­vo Nordisk put out word this morn­ing that at the end of this month, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times